ProZyme Overview
- Year Founded
-
1990
- Status
-
Acquired/Merged
- Employees
-
47
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
ProZyme General Information
Description
Provider of glycobiology research services intended to analyze and optimize life saving therapies. The company's services include developing value-added and customer-driven biochemical reagents, alongside streptavidin, phycobiliprotein and conjugate offerings, enabling large and small biotechnology, bio-pharmaceutical and academic institutions across the world to analyze free glycans.
Contact Information
Website
www.prozyme.comCorporate Office
- 3832 Bay Center Place
- Hayward, CA 94545
- United States
Corporate Office
- 3832 Bay Center Place
- Hayward, CA 94545
- United States
ProZyme Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
ProZyme Comparisons
Industry
Financing
Details
ProZyme Competitors (10)
One of ProZyme’s 10 competitors is Proteintech, a Corporation company based in Rosemont, IL.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Proteintech | Corporation | Rosemont, IL | ||||
Sharp Therapeutics | Venture Capital-Backed | Pittsburgh, PA | ||||
StressMarq Biosciences | Corporation | Victoria, Canada | ||||
Luminex | Corporate Backed or Acquired | Austin, TX | ||||
Standard BioTools | Formerly VC-backed | San Francisco, CA |
ProZyme Patents
ProZyme Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20130171658-A1 | Isolation and deglycosylation of glycoproteins | Inactive | 17-Sep-2010 | ||
EP-2616809-B1 | Isolation and deglycosylation of glycoproteins | Active | 17-Sep-2010 | ||
EP-2616809-A1 | Isolation and deglycosylation of glycoproteins | Active | 17-Sep-2010 | ||
EP-2616809-A4 | Isolation and deglycosylation of glycoproteins | Active | 17-Sep-2010 | ||
ES-2608484-T3 | Compounds and methods for rapid n-glycan labeling | Active | 04-Feb-2008 | C07D207/404 |
ProZyme Signals
ProZyme FAQs
-
When was ProZyme founded?
ProZyme was founded in 1990.
-
Where is ProZyme headquartered?
ProZyme is headquartered in Hayward, CA.
-
What is the size of ProZyme?
ProZyme has 47 total employees.
-
What industry is ProZyme in?
ProZyme’s primary industry is Biotechnology.
-
Is ProZyme a private or public company?
ProZyme is a Private company.
-
What is ProZyme’s current revenue?
The current revenue for ProZyme is
. -
How much funding has ProZyme raised over time?
ProZyme has raised $321K.
-
Who are ProZyme’s competitors?
Proteintech, Sharp Therapeutics, StressMarq Biosciences, Luminex, and Standard BioTools are some of the 10 competitors of ProZyme.
-
When was ProZyme acquired?
ProZyme was acquired on 01-Aug-2018.
-
Who acquired ProZyme?
ProZyme was acquired by Agilent Technologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »